Subject: RE: Disposal instructions for unused drugs************Daily Updates Required- LEPL Social Service Agency
From: Maria Nolasco <[email-masked]>
To: "[email-masked]" <[email-masked]>
Cc: Aida Meskel <[email-masked]>
Date: Tue, 21 Jul 2020 17:25:32 +0000

Hi All,

Could you please provide us the following information.

The quantity, lot and product name

When will product be ready for collection

Thank you.

Regards,

Maria Nolasco

Supply Chain Specialist III

Gilead Sciences Ireland UC

Eagle House, Elm Road

Dublin Airport Logistics Park

St. Margaret’s

Co. Dublin

K67 W240

Ireland

Direct phone: +353 1 2913507

Fax number:  +353 21 4825385

e-mail: [email-masked]

From: Aida Meskel

Sent: Tuesday 7 July 2020 17:12

To: Sinead Daly <[email-masked]>

Cc: Lori Mayall <[email-masked]>; Brendan Power <[email-masked]>; Monique Fahey <[email-masked]>;
Maria Nolasco <[email-masked]>

Subject: RE: Disposal instructions for unused drugs

Hi Sinead,

This is a donation program with the MoH so I don’t believe there is a D.A. I believe there is an MoU with the Minister of Health. Would that help?

Best,

Aida

From: Sinead Daly <[email-masked]>

Sent: Tuesday, July 07, 2020 4:47 AM

To: Aida Meskel <[email-masked]>

Cc: Lori Mayall <[email-masked]>; Brendan Power <[email-masked]>; Monique Fahey <[email-masked]>;
Maria Nolasco <[email-masked]>

Subject: RE: Disposal instructions for unused drugs

Hi Aida,

Please confirm what the DA stipulates and we can review and provide feedback.

Thanks,

Sinead

From: Sean Barr

Sent: Monday 6 July 2020 18:16

To: Aida Meskel <[email-masked]>; Sinead Daly <[email-masked]>

Cc: Lori Mayall <[email-masked]>; Brendan Power <[email-masked]>

Subject: Re: Disposal instructions for unused drugs

Yep, Sinead and team can advise on the process.

Sent from my iPhone

On Jul 6, 2020, at 9:47 AM, Aida Meskel <[email-masked]> wrote:

Thanks Sean.

Lori,

Hope all is well. I can ask them to send it back. Do we have a current process for how this should be handled normally? I wasn’t sure what the process is since I’m new to this role for GPS.

Best,

Aida

From: Lori Mayall <[email-masked]>

Sent: Monday, July 06, 2020 12:32 PM

To: Sean Barr <[email-masked]>; Aida Meskel <[email-masked]>; Brendan Power <[email-masked]>

Subject: RE: Disposal instructions for unused drugs

Hi All – Thank you for the inclusion. We have several active counterfeit cases where expired HARVONI and expired SOVALDI tablets are relabeled with counterfeit HARVONI labels and sold. If feasible, we should have this product returned.

Kind regards, Lori

Lori (she/her/hers)

650-378-2184 (x802184)

From: Sean Barr

Sent: Monday, July 06, 2020 9:24 AM

To: Aida Meskel <[email-masked]>; Lori Mayall <[email-masked]>; Brendan Power <[email-masked]>

Subject: Re: Disposal instructions for unused drugs

+ Brendan and Lori

Might be best to do returns to play it safe and avoid any chance of diversion/counterfeiting.  It looks to be about 7,300 bottles of harvoni and 700 sovaldi.  With that said, we’ve had a good relationship with
with the Georgian MOH so perhaps we can trust them to destroy locally as long as they provide proof of destruction?

Sent from my iPhone

On Jul 6, 2020, at 6:07 AM, Aida Meskel <[email-masked]> wrote:

Hi Sean,

Hope all is well. Quick question, if a country needed help with properly discarding expired product in country, like below with Georgia, is this something you helped facilitate? If so, what was the process to do this? Is there someone I
should reach out to in Gilead to help with this?

Thanks in advance for your help.

Best,

Aida

From: Aysan Murtezaoglu <[email-masked]>

Sent: Tuesday, June 30, 2020 10:51 AM

To: Tamar Gabunia <[email-masked]>; Graeme Robertson <[email-masked]>

Cc: Ron Somers <[email-masked]>; Ekaterine Adamia <[email-masked]>; Aida Meskel <[email-masked]>

Subject: RE: Disposal instructions for unused drugs

Dear Tamar

We are all good and trying to adapt to our new normal working environment.

Graeme is on leave since last week so I have forwarded your email to Aida – our colleague in operations department (supply chain etc). She will provide some info to you hopefully next week as this week our US colleagues
are on holiday.

Best regards

Aysan

From: Tamar Gabunia <[email-masked]>

Sent: 23 Haziran 2020 Salı 20:25

To: Graeme Robertson <[email-masked]>

Cc: Ron Somers <[email-masked]>; Ekaterine Adamia <[email-masked]>; Aysan Murtezaoglu <[email-masked]>

Subject: [EXTERNAL] Disposal instructions for unused drugs

Dear Graeme and Aysan,

I hope all is well with you. I am writing to ask for your advice on the following:  As you are aware, under the National Hepatitis C Elimination program, due to treatment cancelations, patient deaths and other
reasons, there are two different drugs (Sovaldi-16834 tablets and Harvoni-205003 tablets) on balance of LEPL Social Service Agency, which were not utilized. The drugs belong to a category of “expired/unusable” and are subject of disposal in accordance with
the laws of Georgia.

We would be grateful if you could provide any recommendations or additional instructions on the above mentioned subject.

Thank you in advance.

პატივისცემით,

თამარ გაბუნია

მინისტრის პირველი მოადგილე

Sincerely,

Tamar Gabunia,
MD, MPH

First Deputy Minister

DISCLAIMER If you have received this message in error, please contact the sender immediately by return e-mail and notify the sender and then delete this message (including any attachments) from your system. This communication and any attachments contain information
which is confidential and may also be legally privileged. It is for the exclusive use of the intended recipient(s). If you are not the intended recipient(s) please note that any form of disclosure, distribution, copying or use of this communication or the
information in it or in any attachments is strictly prohibited and may be unlawful. If your e-mail contains any personal information then we will process this according to our Privacy Statement located on
Gilead.com. E-mail communications cannot be guaranteed to be secure or error free, as information could be intercepted, corrupted, amended, lost, destroyed, arrive late or incomplete, or contain
viruses. Gilead does not accept liability for any such matters or their consequences. Anyone who communicates with Gilead by e-mail is taken to accept the risks in doing so. Gilead has taken every reasonable precaution to ensure that any attachment to this
e-mail has been swept for viruses. However, Gilead cannot accept liability for any damage sustained as a result of viruses and would advise that you carry out your own virus checks before opening any attachment. Gilead Sciences Europe Ltd ; Registered as a
limited company in England and Wales ; Registered number 5510315 Registered office: South Building ; 2 Roundwood Avenue ; Stockley Park ; Uxbridge ; UB11 1AF ; England